|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Appin CL and Brat DJ: Molecular pathways
in gliomagenesis and their relevance to neuropathologic diagnosis.
Adv Anat Pathol. 22:50–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tanaka S, Louis DN, Curry WT, Batchelor TT
and Dietrich J: Diagnostic and therapeutic avenues for
glioblastoma: No longer a dead end? Nat Rev Clin Oncol. 10:142013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalpathy-Cramer J, Gerstner ER, Emblem KE,
Andronesi O and Rosen B: Advanced magnetic resonance imaging of the
physical processes in human glioblastoma. Cancer Res. 74:4622–4637.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dlouhá D and Hubáček JA: Regulatory RNAs
and cardiovascular disease-with a special focus on circulating
microRNAs. Physiol Res. 66 (Suppl 1):S21–S38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu HS, Zong HL, Shang M, Ming X, Zhao JP,
Ma C and Cao L: MiR-324-5p inhibits proliferation of glioma by
target regulation of GLI1. Eur Rev Med Pharmacol Sci. 18:828–832.
2014.PubMed/NCBI
|
|
8
|
Duan R, Han L, Wang Q, Wei J, Chen L,
Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic
marker and promotes glioma invasion by activating the Wnt and TGF-β
pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui R, Guan Y, Sun C, Chen L, Bao Y, Li G,
Qiu B, Meng X, Pang C and Wang Y: A tumor-suppressive microRNA,
miR-504, inhibits cell proliferation and promotes apoptosis by
targeting FOXP1 in human glioma. Cancer Lett. 374:1–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gu Y, Zhang Z, Yin J, Ye J, Song Y, Liu H,
Xiong Y, Lu M, Zheng G and He Z: Epigenetic silencing of miR-493
increases the resistance to cisplatin in lung cancer by targeting
tongue cancer resistance-related protein 1(TCRP1). J Exp Clin
Cancer Res. 36:1142017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mo FF, An T, Zhang ZJ, Liu YF, Liu HX, Pan
YY, Miao JN, Zhao DD, Yang XY, Zhang DW, et al: Jiang Tang Xiao Ke
Granule Play an anti-diabetic role in diabetic mice pancreatic
tissue by regulating the mRNAs and MicroRNAs associated with
PI3K-Akt signaling pathway. Front Pharmacol. 8:7952017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Milano MT, Johnson MD, Sul J, Mohile NA,
Korones DN, Okunieff P and Walter KA: Primary spinal cord glioma: A
surveillance, epidemiology, and end results database study. J
Neurooncol. 98:83–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jansen M, Yip S and Louis DN: Molecular
pathology in adult gliomas: Diagnostic, prognostic, and predictive
markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Riddick G and Fine HA: Integration and
analysis of genome-scale data from gliomas. Nat Rev Neurol.
7:439–450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schratt GM, Tuebing F, Nigh EA, Kane CG,
Sabatini ME, Kiebler M and Greenberg ME: A brain-specific microRNA
regulates dendritic spine development. Nature. 439:283–289. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davis-Dusenbery BN and Hata A: MicroRNA in
cancer: The involvement of aberrant MicroRNA biogenesis regulatory
pathways. Genes Cancer. 1:1100–1114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Molina-Pinelo S, Suárez R, Pastor MD,
Nogal A, Márquez-Martín E, Martín-Juan J, Carnero A and Paz-Ares L:
Association between the miRNA signatures in plasma and
bronchoalveolar fluid in respiratory pathologies. Dis Markers.
32:221–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sud N, Zhang H, Pan K, Cheng X, Cui J and
Su Q: Aberrant expression of microRNA induced by high-fructose
diet: Implications in the pathogenesis of hyperlipidemia and
hepatic insulin resistance. J Nutr Biochem. 43:125–131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang G, Ma Y, An T, Pan Y, Mo F, Zhao D,
Liu Y, Miao JN, Gu YJ, Wang Y and Gao SH: Relationships of circular
RNA with diabetes and depression. Sci Rep. 7:72852017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu
P, Song Z, Qian C, Chen Y, Yang S and Wang Y: miR-92b controls
glioma proliferation and invasion through regulating
Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol.
15:578–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Qi Y, Geng D, Shi Y, Wang X, Yu R
and Zhou X: Expression profile and clinical significance of Wnt
signaling in human gliomas. Oncol Lett. 15:6102018.PubMed/NCBI
|
|
22
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong L, Qi N, Ge RM, Cao CL, Lan F and
Shen L: Overexpression of CD133 promotes the phosphorylation of Erk
in U87MG human glioblastoma cells. Neurosci Lett. 484:210–214.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang BQ, Yang B, Yang HC, Wang JY, Hu S,
Gao YS and Bu XY: MicroRNA-499a decelerates glioma cell
proliferation while accelerating apoptosis through the suppression
of Notch1 and the MAPK signaling pathway. Brain Res Bull.
142:96–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang R, Deng D, Shao N, Xu Y, Xue L, Peng
Y, Liu Y and Zhi F: Evodiamine activates cellular apoptosis through
suppressing PI3K/AKT and activating MAPK in glioma. Onco Targets
Ther. 11:1183–1192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishibe Y, Kusaoi M, Murayama G, Nemoto T,
Kon T, Ogasawara M, Kempe K, Yamaji K and Tamura N: Changes in the
expression of circulating microRNAs in systemic lupus erythematosus
patient blood plasma after passing through a plasma adsorption
membrane. Ther Apher Dial. 22:278–289. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mo LJ, Song M, Huang QH, Guan H, Liu XD,
Xie DF, Huang B, Huang RX and Zhou PK: Exosome-packaged miR-1246
contributes to bystander DNA damage by targeting LIG4. Br J Cancer.
119:492–502. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moshiri F, Salvi A, Gramantieri L,
Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari
A, Cheung D, et al: Circulating miR-106b-3p, miR-101-3p and
miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.
Oncotarget. 9:15350–15364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zhang C, Zhang P, Guo G, Jiang T,
Zhao X, Jiang J, Huang X, Tong H and Tian Y: Serum exosomal
microRNAs combined with alpha-fetoprotein as diagnostic markers of
hepatocellular carcinoma. Cancer Med. 7:1670–1679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bhagirath D, Yang TL, Bucay N, Sekhon K,
Majid S, Shahryari V, Dahiya R, Tanaka Y and Saini S: MicroRNA-1246
is an exosomal biomarker for aggressive prostate cancer. Cancer
Res. 78:1833–1844. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li XJ, Ren ZJ, Tang JH and Yu Q: Exosomal
MicroRNA MiR-1246 promotes cell proliferation, invasion and drug
resistance by targeting CCNG2 in breast cancer. Cell Physiol
Biochem. 44:1741–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen SM, Chen HC, Chen SJ, Huang CY, Chen
PY, Wu TW, Feng LY, Tsai HC, Lui TN, Hsueh C and Wei KC:
MicroRNA-495 inhibits proliferation of glioblastoma multiforme
cells by downregulating cyclin-dependent kinase 6. World J Surg
Oncol. 11:872013. View Article : Google Scholar : PubMed/NCBI
|
